-+ 0.00%
-+ 0.00%
-+ 0.00%

IGM Biosciences Q1 EPS $(0.50) Misses $(0.48) Estimate, Sales $499.00K Miss $3.10M Estimate

Benzinga·05/14/2025 05:30:19
Listen to the news
IGM Biosciences (NASDAQ:IGMS) reported quarterly losses of $(0.50) per share which missed the analyst consensus estimate of $(0.48) by 4.17 percent. This is a 39.76 percent increase over losses of $(0.83) per share from the same period last year. The company reported quarterly sales of $499.00 thousand which missed the analyst consensus estimate of $3.10 million by 83.91 percent. This is a 0.40 percent increase over sales of $497.00 thousand the same period last year.